Alzheimer's disease a century later.

Alzheimer's disease a century later. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Alzheimer's disease a century later. Abstract Text:

OBJECTIVE: To provide a current survey of the clinical and pathologic features, known genetic and suggested pathogenic contributions, diagnosis, and treatment of Alzheimer's disease (AD) and related forms of dementia. DATA SOURCES: PubMed was searched for specific indexing terms identified by the authors as relevant to the topic. Also included were diagnostic and consensus criteria and classic references long standing in the Alzheimer's disease literature. DATA SYNTHESIS: AD is the most common form of disabling cognitive impairment in older persons, and its prevalence is rapidly growing as people live to older ages. Clinically, the disorder is characterized by a gradual but progressive decline in memory and other cognitive domains and the frequent occurrence of noncognitive behavioral symptoms. Neuropathologically, the cardinal features of AD include neuritic plaques, neuro-fibrillary tangles, and the loss of synapses and neurons. The clinical evaluation of AD includes a history and physical examination, laboratory tests, and structural brain imaging to exclude less common forms of dementia. The clinical management of AD includes medication and nonmedication strategies for addressing cognitive, behavioral, and other commonly associated symptoms of patients as well as lifestyle changes such as driving cessation and residential care. Genetic causes of familial Alzheimer's disease as well as genes that predispose to late-onset and sporadic Alzheimer's disease have led to greater understanding of the pathophysiology of the neurodegenerative process. CONCLUSIONS: While there has been great promise in the scientific understanding, early detection, and tracking of AD and in the discovery of promising disease-slowing treatments, there remains an unmet urgent need to identify effective primary and secondary prevention therapies in order to avert a financially overwhelming public health problem.

Alzheimer's disease a century later. Publishing Authors By Initials

For similar pathological conditions, signs and symptoms: pathologic processes: sclerosis research abstracts see: pathological conditions, signs and symptoms: pathologic processes: sclerosis research

PUBMED ID PMID:

MEDLINE DATE:

Alzheimer's disease a century later. Journal Published:

PUBLICATION TYPE: Review

Journal: The Journal of clinical psychiatry

VOLUME: 67

Page Numbers: 1784-800

Journal Abbreviation:

ISSN: 1555-2101

DAY: 3

MONTH: Nov

YEAR: 2006

Alzheimer's disease a century later. Information

Number of References: 209

LANGUAGE: eng

NlmUniqueID: 7801243

Alzheimer's disease a century later. Keywords Mesh Terms:

KEYWORDS: Sclerosis

MESH TERMS: pathology

Chemical & Substance for Abstract: Alzheimer's disease a century later. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Alzheimer's disease a century later.

AFFILIATION: Department of Neurology, Mayo Clinic and Arizona Alzheimer's Disease Consortium, Scottsdale 85259, USA. Caselli.Richard@Mayo.edu

Country: United States

AGENCY: United States NIA

GRANT: P30 AG19610-01

ACRONYM: AG

MEDLINETA: J Clin Psychiatry

REFSOURCE: J Clin Psychiatry. 2006 Nov;67(11):1782-

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Alzheimer's disease a century later Related Publications

• Alzheimer's disease a century later.
• Aurora A kinase RNAi and small molecule inhibition of Aurora kinases with VE-465 induce apoptotic death in multiple myeloma cells.
• Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10.
• Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment.
• Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions.
• FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice.
• Immunoglobulin G antibodies of children exposed to microorganisms in a water-damaged school.
• Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment.
• Linking brain imaging and genomics in the study of Alzheimer's disease and aging.
• Primary retroperitoneal neoplasms: CT findings in 90 cases with clinical and pathologic correlation.
• Results of a survey on current surgical smoke control practices.
• Self-efficacy, social support and service integration at medical cannabis facilities in the San Francisco Bay area of California.
• Stabilization of the vertical mode in tokamaks by localized nonaxisymmetric fields.
• The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma.